Rhomboid domain containing 2 (RHBDD2): A novel cancer-related gene over-expressed in breast cancer

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1792, Issue 10, 2009, Pages 988-997

  Abba, M C ^a,b   Lacunza, E ^a   Nunez, M I ^b   Colussi, A ^a   Isla Larrain, M ^a   Segal Eiras, A ^a   Croce, M V ^a   Aldaz, C M ^b  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Breast cancer; Gene amplification; Gene expression profile; RHBDD2

Indexed keywords

COMPLEMENTARY DNA; MEMBRANE PROTEIN; MESSENGER RNA; RHOMBOID DOMAIN CONTAINING 2 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER STAGING; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA SEQUENCE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION; WESTERN BLOTTING;

ALTERNATIVE SPLICING; BASE SEQUENCE; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA MUTATIONAL ANALYSIS; EPITHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROGNOSIS; RNA, MESSENGER; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL;

EID: 70349270573     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2009.07.006     Document Type: Article

References (18)

1. Abba M.C., Sun H., Hawkins K.A., Drake J.A., Hu Y., Nunez M.I., et al. Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status. Mol. Cancer Res. 5 9 (2007) 881-890
2. Lemberg M.K., and Freeman M. Functional and evolutionary implications of enhanced genomic analysis of rhomboid intramembrane proteases. Genome Res. 17 11 (2007) 1634-1646
3. Jeyaraju D.V., Xu L., Letellier M., Bandaru S., Zunino R., Berg E.A., et al. Phosphorylation and cleavage of presenilin-associated rhomboid-like protein (PARL) promotes changes in mitochondrial morphology. Proc. Natl. Acad. Sci. U. S. A. 103 49 (2006) 18562-18567
4. Cipolat S., Rudka T., Hartmann D., Costa V., Serneels L., Craessaerts K., et al. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126 1 (2006) 163-175
5. Urban S. Rhomboid proteins: conserved membrane proteases with divergent biological functions. Genes Dev. 20 22 (2006) 3054-3068
6. Abba M.C., Hu Y., Sun H., Drake J.A., Gaddis S., Baggerly K., et al. Gene expression signature of estrogen receptor alpha status in breast cancer. BMC Genomics 6 1 (2005) 37
7. Abba M.C., Laguens R.M., Dulout F.N., and Golijow C.D. The c-myc activation in cervical carcinomas and HPV 16 infections. Mutat. Res. 557 2 (2004) 151-158
8. Abba M.C., Fabris V.T., Hu Y., Kittrell F.S., Cai W., Donehower L.A., et al. Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34. Cancer Res. 67 9 (2007 May 1) 4104-4112
9. Baudis M., and Cleary M.L. Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 17 12 (2001) 1228-1229
10. van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A.M., Voskuil D.W., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347 25 (2002) 1999-2009
11. Lee C., Atanelov L., Modrek B., and Xing Y. ASAP: the Alternative Splicing Annotation Project. Nucleic Acids Res. 31 1 (2003) 101-105
12. Pollack J.R., Sørlie T., Perou C.M., Rees C.A., Jeffrey S.S., Lonning P.E., et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. U. S. A. 99 20 (2002) 12963-12968
13. La Rosa P., Viara E., Hupé P., Pierron G., Liva S., Neuvial P., et al. VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles. Bioinformatics 22 17 (2006) 2066-2073
14. Hupé P., La Rosa P., Liva S., Lair S., Servant N., and Barillot E. ACTuDB, a new database for the integrated analysis of array-CGH and clinical data for tumors. Oncogene 26 46 (2007) 6641-6652
15. Forozan F., Mahlamäki E.H., Monni O., Chen Y., Veldman R., Jiang Y., et al. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res. 60 16 (2000) 4519-4525
16. Yan Z., Zou H., Tian F., Grandis J.R., Mixson A.J., Lu P.Y., et al. Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth. Mol. Cancer Ther. 7 6 (2008) 1355-1364
17. Zhou Y., Luoh S., Zhang Y., Watanabe C., Wu T.D., Ostland M., et al. Genome-wide identification of chromosomal regions of increased tumor expression by transcriptome analysis. Cancer Res. 63 18 (2003) 5781-5784
18. Zou H., Thomas S.M., Yan Z., Grandis J.R., Vogt A., and Li L. Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells. FASEB J. 23 2 (2009) 425-432